FILTER

FILTERED INTERVIEW RESULTS

Federico Chinni

MANAGING DIRECTOR, UCB ITALY
UCB Italy explains the specifications of the Italian health and pharma sector.

Fabrizio Chines

CHAIRMAN & CEO, SIFI GROUP
SIFI Group explains its pipeline and its plans for expansion in the ophthalmology space.

Massimo Scaccabarozzi

PRESIDENT, FARMINDUSTRIA
Farmindustria speaks to GBR about the importance of pharmaceuticals to the Italian economy and society.

Massimiliano Rocchi

SENIOR DIRECTOR ITALY AND GREECE, ACCORD HEALTHCARE ITALIA
Accord Healthcare Italia explains the challenges and opportunities for generics producers in Italy.

Luca Crippa

CEO & MANAGING DIRECTOR, IBSA FARMACEUTICI
Instituto Biochimico, with 2,000 global employees, is attempting to take generics to the next level and continue to expand around the world.

Franco Lori

CEO & FOUNDER, VIROSTATICS
Virostatics is a private drug discovery and development company focused on NCEs used in the treatment of cancers and viral diseases.

Cosimo Lenti

BUSINESS DIRECTOR, DIATHEVA
Diatheva promotes biotechnological innovation by providing high-value customized diagnostic kits and solutions.

Gilda D'Incerti

CEO AND FOUNDER, PQE GROUP
PQE Group explains its imperative to expand rapidly apace with the global life science industry.

Andrea Lodetti

CEO, BORMIOLI PHARMA
Bormioli Pharma discusses its plans to maintain its expansion.

Riccardo Palmisano

PRESIDENT, ASSOBIOTEC
Federchimica Assobiotec explains how the association is striving to help Italy’s biotech industry reach the scale that its’ potential offers.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

MACIG Southern Africa 2021 - Digital Version

PARTNER EVENTS